Abstract | BACKGROUND: METHODS: RESULTS: Forty-four melanomas (100%), including all 3 spindle-cell melanomas, were positive for Mitf. All nonmelanoma neoplasms were negative with only one exception: One mammary carcinoma showed rare (< 10%), weak nuclear staining with Mitf. The sensitivity and specificity of Mitf as a marker for melanoma were both 100%, whereas the sensitivity of HMB-45 antigen was 90.4%, and the specificity of S-100 protein was 70.3%. CONCLUSIONS: Mitf is a sensitive and specific marker for malignant melanoma, including the spindle-cell variant, in cytologic specimens and may be superior to the current standard melanocytic markers, S-100 protein and HMB-45 antigen.
|
Authors | C C Dorvault, K N Weilbaecher, H Yee, D E Fisher, L A Chiriboga, Y Xu, D C Chhieng |
Journal | Cancer
(Cancer)
Vol. 93
Issue 5
Pg. 337-43
(Oct 25 2001)
ISSN: 0008-543X [Print] United States |
PMID | 11668469
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright 2001 American Cancer Society. |
Chemical References |
- Antibodies, Monoclonal
- Antigens, Neoplasm
- Biomarkers, Tumor
- DNA-Binding Proteins
- MITF protein, human
- Melanoma-Specific Antigens
- Microphthalmia-Associated Transcription Factor
- Neoplasm Proteins
- S100 Proteins
- Transcription Factors
|
Topics |
- Antibodies, Monoclonal
- Antigens, Neoplasm
- Biomarkers, Tumor
(analysis)
- DNA-Binding Proteins
(analysis)
- Humans
- Immunohistochemistry
(standards)
- Melanoma
(pathology, secondary)
- Melanoma-Specific Antigens
- Microphthalmia-Associated Transcription Factor
- Neoplasm Proteins
(analysis)
- Predictive Value of Tests
- Retrospective Studies
- S100 Proteins
(analysis)
- Sensitivity and Specificity
- Skin Neoplasms
(pathology)
- Transcription Factors
(analysis)
|